Browse by Publication
![]() | Up a level |
Number of items: 10.
C
Caterson, ID;
Finer, N;
Coutinho, W;
Van Gaal, LF;
Maggioni, AP;
Torp-Pedersen, C;
Sharma, AM;
Legler, UF;
Shepherd, GM;
Rode, RA;
+4 more...
Perdok, RJ;
Renz, CL;
James, WP;
on the behalf of the SCOUT Investigators;
(2011)
Maintained Intentional Weight Loss Reduces Cardiovascular Outcomes: Results from the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.
Diabetes, obesity & metabolism.
ISSN 1462-8902
DOI: https://doi.org/10.1111/j.1463-1326.2011.01554.x
Full text not available from this repository.
G
Goring, S;
Hawkins, N;
Wygant, G;
Roudaut, M;
Townsend, R;
Wood, I;
Barnett, AH;
(2013)
Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: A systematic review and network meta-analysis.
Diabetes, obesity & metabolism, 16.
pp. 433-442.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12239
Full text not available from this repository.
H
Hermansen, K;
Davies, M;
(2007)
[DUMMY]Does insulin detemir have a role in reducing risk of insulin-associated weight gain?
Diabetes, obesity & metabolism, 9 (3).
pp. 209-17.
ISSN 1462-8902
DOI: https://doi.org/10.1111/j.1463-1326.2006.00665.x
Full text not available from this repository.
Hermansen, K;
Kipnes, M;
Luo, E;
Fanurik, D;
Khatami, H;
Stein, P;
Sitagliptin Study 035 Group;
(2007)
[DUMMY]Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Diabetes, obesity & metabolism.
ISSN 1462-8902
DOI: https://doi.org/10.1111/j.1463-1326.2007.00744.x
Full text not available from this repository.
K
Khunti, K;
Godec, TR;
Medina, J;
Garcia-Alvarez, L;
Hiller, J;
Gomes, MB;
Cid-Ruzafa, J;
Charbonnel, B;
Fenici, P;
Hammar, N;
+6 more...
Hashigami, K;
Kosiborod, M;
Nicolucci, A;
Shestakova, MV;
Ji, L;
Pocock, S;
(2017)
Patterns of glycaemic control in patients with type 2 diabetes mellitus initiating second-line therapy after metformin monotherapy: Retrospective data for 10 256 individuals from the United Kingdom and Germany.
Diabetes, obesity & metabolism.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.13083
Khunti, K;
Gomes, MB;
Pocock, S;
Shestakova, MV;
Pintat, S;
Fenici, P;
Hammar, N;
Medina, J;
(2017)
Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: a systematic review.
Diabetes, obesity & metabolism.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.13088
L
Louet, JF;
Smith, SB;
Gautier, JF;
Molokhia, M;
Virally, ML;
Kevorkian, JP;
Guillausseau, PJ;
Vexiau, P;
Charpentier, G;
German, MS;
+3 more...
Vaisse, C;
Urbanek, M;
Mauvais-Jarvis, F;
(2007)
Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes.
Diabetes, obesity & metabolism, 10 (10).
pp. 912-20.
ISSN 1462-8902
DOI: https://doi.org/10.1111/j.1463-1326.2007.00830.x
Full text not available from this repository.
N
Nauck, MA;
Buse, JB;
Mann, JFE;
Pocock, S;
Bosch-Traberg, H;
Frimer-Larsen, H;
Ye, Q;
Gray, A;
LEADER Publication Committee for the LEADER Trial Investigators;
(2018)
Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.
Diabetes, obesity & metabolism.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.13547
S
Strongman, H;
D'Oca, K;
Langerman, H;
Das, R;
(2015)
Comparison of diabetes-associated secondary healthcare utilization between alternative oral antihyperglycaemic dual therapy combinations with metformin in patients with type 2 diabetes: an observational cohort study.
Diabetes, obesity & metabolism, 17 (6).
pp. 573-80.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12458
Full text not available from this repository.
Z
Zomer, E;
Leach, R;
Trimmer, C;
Lobstein, T;
Morris, S;
James, WP;
Finer, N;
(2016)
Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.
Diabetes, obesity & metabolism, 19 (1).
pp. 118-124.
ISSN 1462-8902
DOI: https://doi.org/10.1111/dom.12792